Stock Report

Earum Pharmaceuticals Ltd Q2 FY2023 profit at Rs. 3.67 lakhs



Posted On : 2022-11-06 14:28:07( TIMEZONE : IST )

Earum Pharmaceuticals Ltd Q2 FY2023 profit at Rs. 3.67 lakhs

has reported Standalone financial results for the period ended September 30, 2022.

Financial Results (Q2 FY2023) - QoQ Comparison

The company has reported total income of Rs. 7.1144 crores during the period ended September 30, 2022 as compared to Rs. 5.1444 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs. 0.0367 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 0.3630 crores for the period ended June 30, 2022.

The company has reported EPS of Rs. 0.003 for the period ended September 30, 2022 as compared to Rs. 0.29 for the period ended June 30, 2022.

Financials Q2 FY2023 Q1 FY2023 % Change
Total Income ₹ 7.1144 crs ₹5.1444 crs Up Tick / Down Tick38.29%
Net Profit ₹0.0367 crs ₹0.3630 crs Up Tick / Down Tick-89.89%
EPS ₹0.003 ₹0.29 Up Tick / Down Tick-98.97%

Financial Results (Q2 FY2023) - YoY Comparison

The company has reported total income of Rs. 7.1144 crores during the period ended September 30, 2022 as compared to Rs.10.6233 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.0.0367 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.5.3997 crores for the period ended September 30, 2021.

The company has reported EPS of Rs.0.003 for the period ended September 30, 2022 as compared to Rs.4.38 for the period ended September 30, 2021.

Financials Q2 FY2023 Q2 FY2022 % Change
Total Income ₹ 7.1144 crs ₹10.6233 crs Up Tick / Down Tick-33.03%
Net Profit ₹0.0367 crs ₹5.3997 crs Up Tick / Down Tick-99.32%
EPS ₹0.003 ₹4.38 Up Tick / Down Tick-99.93%

Financial Results (Half Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.12.2588 crores during the 6 Months period ended September 30, 2022 as compared to Rs.13.6934 crores during the 6 Months period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.0.3997 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.1.9867 crores for the 6 Months period ended September 30, 2021.

The company has reported EPS of Rs.0.03 for the 6 Months period ended September 30, 2022 as compared to Rs.1.56 for the 6 Months period ended September 30, 2021.

Financials Half Year Ended FY2023 Half Year Ended FY2022 % Change
Total Income ₹12.2588 crs ₹13.6934 crs Up Tick / Down Tick-10.48%
Net Profit ₹0.3997 crs ₹1.9867 crs Up Tick / Down Tick-79.88%
EPS ₹0.03 ₹1.56 Up Tick / Down Tick-98.08%

Source : Equity Bulls

Keywords

EarumPharmaceuticals Q2FY23 H1FY23 ResultUpdate